Navigating Cancer Information Trust in a Time of Distrust Fragmentation
-
By
-
Skyler B. Johnson
-
August 31, 2026
By
Skyler B. Johnson
August 31, 2026
A first-in-human study reduces stem-cell collection and manufacturing times, Bristol Myers ends its Breyanzi agreement with Cellares, and two approaches strengthen CAR T-cell activity against solid tumors
August 31, 2026